Continuous exposure of PM2.5 exacerbates ovalbumin-induced asthma in mouse lung via a JAK-STAT6 signaling pathway

Yonghui Yang1, Xiaoxia Li1, Xiaoying An2

  • 1Department of Pathology, Hebei Province Chest Hospital, Lung Cancer Prevention and Control Center of Hebei Province, Shijiazhuang, China.

Abstract

Insights

Continuous exposure to fine particulate matter (PM2.5) significantly worsens asthma by increasing lung inflammation and injury. This exacerbation is mediated by the JAK-STAT6 signaling pathway, highlighting the detrimental effects of prolonged air pollution exposure.

Area of Science:

  • Environmental Health
  • Immunology
  • Respiratory Medicine

Background:

  • Air pollution, specifically fine particulate matter (PM2.5), is known to worsen asthma in humans.
  • Epidemiological studies and animal models link PM2.5 exposure to acute asthma exacerbations.

Purpose of the Study:

  • To investigate how continuous PM2.5 exposure affects asthma regulation.
  • To compare the impact of continuous PM2.5 exposure versus single exposure on asthma mechanisms.

Main Methods:

  • Wild-type mice were subjected to either single or five exposures of PM2.5 and ovalbumin (OVA) over 27 days.
  • Asthma induction and eosinophil recruitment were assessed under continuous and single PM2.5 exposure conditions.

Main Results:

  • Continuous PM2.5 exposure significantly elevated total IgE, inflammatory cells (eosinophils, macrophages) in BALF, and lung injury.
  • Increased production of cytokines (IL-1β, MCP-1, IL-12, IL-5, IL-13) and PGD2 was observed.
  • Eosinophil recruitment was regulated via the JAK/STAT6 pathway phosphorylation.

Conclusions:

  • Continuous PM2.5 exposure exacerbates OVA-induced asthma in mice.
  • The JAK-STAT6 signaling pathway plays a crucial role in mediating PM2.5-induced asthma exacerbation.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.1K